Tricetin, a Dietary Flavonoid, Inhibits Proliferation of Human Breast Adenocarcinoma MCF-7 Cells by Blocking Cell Cycle Progression and Inducing Apoptosis

被引：51

作者：

Hsu, Ya-Ling ^{[2
]}

Uen, Yih-Huei ^{[3
]}

Chen, Yi ^{[3
]}

Liang, Hsin-Lin ^{[4
]}

Kuo, Po-Lin ^{[1
,5
]}

机构：

[1] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung 807, Taiwan

[2] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan

[3] Chi Mei Fdn, Med Ctr, Dept Surg, Div Gen Surg, Young Kang City 710, Tainan, Taiwan

[4] Kaohsiung Municipal United Hosp, Dept Pharmacol, Kaohsiung 804, Taiwan

[5] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan

来源：

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY | 2009年 / 57卷 / 18期

关键词：

Tricetin; ATM; p53; cell cycle; apoptosis; DNA-DAMAGE; EUCALYPTUS HONEYS; CANCER CELLS; P53; PROTEIN; PHOSPHORYLATION; ARREST; ATM; ACTIVATION; CHECKPOINT; PATHWAY;

D O I：

10.1021/jf901053x

中图分类号：

S [农业科学];

学科分类号：

09 ;

摘要：

This study is the first to investigate the anticancer effect of tricetin in human breast adenocarcinoma (ATM). Activation of ATM by tricetin phosphorylated p53 at serine 15. (MDM2) interaction. In addition, tricetin-mediated G2/M phase arrest was also associated with decreases in (serine 15) and Chk2. Tricetin-induced apoptotic cell

引用

页码：8688 / 8695

页数：8

共 37 条

[1] THE EPIDERMAL GROWTH-FACTOR RECEPTOR AS A TARGET FOR THERAPY IN BREAST-CARCINOMA [J].

BASELGA, J ;

MENDELSOHN, J .

BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) :127-138

[2] The mismatch repair system is required for S-phase checkpoint activation [J].

Brown, KD ;

Rathi, A ;

Kamath, R ;

Beardsley, DI ;

Zhan, QM ;

Mannino, JL ;

Baskaran, R .

NATURE GENETICS, 2003, 33 (01) :80-84

[3] Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint [J].

Bruno, Tiziana ;

De Nicola, Francesca ;

Iezzi, Simona ;

Lecis, Daniele ;

D'Angelo, Carmen ;

Di Padova, Monica ;

Corbi, Nicoletta ;

Dimiziani, Leopoldo ;

Zannini, Laura ;

Jekimovs, Christian ;

Scarsella, Marco ;

Porrello, Alessandro ;

Chersi, Alberto ;

Crescenzi, Marco ;

Leonetti, Carlo ;

Khanna, Kum Kum ;

Soddu, Silvia ;

Floridi, Aristide ;

Passananti, Claudio ;

Delia, Domenico ;

Fanciulli, Maurizio .

CANCER CELL, 2006, 10 (06) :473-486

[4]

Campos MG, 2002, Z NATURFORSCH C, V57, P944

[5] The intricacies of p21 phosphorylation - Protein/protein interactions, subcellular localization and stability [J].

Child, Emma S. ;

Mann, David J. .

CELL CYCLE, 2006, 5 (12) :1313-1319

[6] Endocrine and Targeted Manipulation of Breast Cancer: Summary statement for the Sixth Cambridge Conference [J].

Come, Steven E. ;

Buzdar, Aman U. ;

Ingle, James N. ;

Johnston, Stephen R. D. ;

Brodie, Angela M. ;

Coombes, R. Charles ;

Miller, William R. ;

Pritchard, Kathleen I. ;

Winer, Eric P. ;

Zujewski, Jo Anne ;

Goss, Paul E. .

CANCER, 2008, 112 (03) :673-678

[7] ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage [J].

Dornan, David ;

Shimizu, Harumi ;

Mah, Angie ;

Dudhela, Tanay ;

Eby, Michael ;

O'Rourke, Karen ;

Seshagiri, Somasekar ;

Dixit, Vishva M. .

SCIENCE, 2006, 313 (5790) :1122-1126

[8] Development of new targeted therapies for breast cancer [J].

Doyle, Danielle M. ;

Miller, Kathy D. .

BREAST CANCER, 2008, 15 (01) :49-56

[9] THE LIFETIME RISK OF DEVELOPING BREAST-CANCER [J].

FEUER, EJ ;

WUN, LM ;

BORING, CC ;

FLANDERS, WD ;

TIMMEL, MJ ;

TONG, T .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (11) :892-897

[10] Lost in transcription: p21 repression, mechanisms, and consequences [J].

Gartel, AL ;

Radhakrishnan, SK .

CANCER RESEARCH, 2005, 65 (10) :3980-3985

← 1 2 3 4 →